ELIZABETH DRAKE: Open Payments
NPI 1215451190 · WINTER GARDEN, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,110 in 42 payments from 16 companies in 2025. Trend: 2023 $1,697 · 2024 $1,398 · 2025 $1,110
Food & beverage: $1,110
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $390 |
| ABBVIE INC. | 4 | $88 |
| Xeris Pharmaceuticals, Inc. | 4 | $78 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $72 |
| Amneal Pharmaceuticals LLC | 3 | $64 |
| Madrigal Pharmaceuticals | 2 | $63 |
| Lilly USA, LLC | 3 | $57 |
| CeQur Corporation | 1 | $51 |
| RECORDATI_RARE_DISEASES_INC. | 2 | $47 |
| Amgen Inc. | 2 | $43 |
Products named: Ozempic, Wegovy, GVOKE HYPOPEN, Kerendia, UBRELVY, UNITHROID, REZDIFFRA, CeQur Simplicity.
Industry payments across FL — which companies pay providers there.
